Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease mccune-albright syndrome
Comorbidity C0034013|precocious puberty
Sentences 3
PubMedID- 22051789 Summary and conclusion: although different in presentation, all three atypical cases of suspected mccune-albright syndrome with gonadotropin-independent precocious puberty were successfully treated with aromatase inhibitors.
PubMedID- 22068112 Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to mccune-albright syndrome.
PubMedID- 22999294 The objective of this study was to evaluate the safety and efficacy of fulvestrant (faslodextm), a pure estrogen receptor antagonist, in girls with progressive precocious puberty (pp) associated with mccune-albright syndrome (mas).

Page: 1